InvestorsHub Logo
Followers 8
Posts 1894
Boards Moderated 0
Alias Born 05/05/2016

Re: thesaud post# 15495

Thursday, 09/13/2018 7:52:16 PM

Thursday, September 13, 2018 7:52:16 PM

Post# of 44784
Hi Saud, thanks for the very interesting link! The article nicely reiterates what we know and hope for Pluristem.
I like Dr.Weiss's comment below, I hope he was choosing his words carefully! The number of patients is quite staggering. If the study results are just statistically significant (I'm hoping for better, given that patients were able to walk 83% farther, and no revasc surgeries at all, looks like a real major therapy), the company will take off like a rocket.


Pluristem’s recent study results are highly encouraging and suggest that PLX-PAD cells may be the answer for both PAD patients and physicians seeking effective medical solutions,” says Professor Norbert Weiss, M.D., Director of the Vascular Center at the Technical University of Dresden, and the lead principal investigator for the European part of the study.